Leveraging Real-world Evidence in a Rare Disease Oncology Drug Approval

Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-world Evidence and FDA/Regulatory expertise to develop and execute a Synthetic Control Arm approach.

Previous Flipbook
Impact of Clinical Trials in Rare Disease and Oncology
Impact of Clinical Trials in Rare Disease and Oncology

Next Flipbook
Whitepaper: COVID-19 Vaccination in Cancer Patients
Whitepaper: COVID-19 Vaccination in Cancer Patients

×

Let's start a conversation...

First Name
Last Name
Job Title
Company Name
Country
Therapeutic Area Interest - optional
Tell us how we can help
Thank you! We'll be in touch soon.
Error - something went wrong!